Pacific Biosciences IPO Priced At $16 – Benzinga


Pacific Biosciences IPO Priced At $16
Benzinga
Pacific Biosciences of California said its initial public offering will price at $16 a share, in the middle of the expected range. The company, which will trade under the ticker "PACB" will sell 12.5 million shares today, raising $200
Pacific Biosciences Raises $200 Million Pricing IPO at Midpoint of Range Bloomberg


Pacific Biosciences raises $200M in IPO Bizjournals.com
Pacific Biosciences Looks to Raise $200M through $16 per Share IPO Genetic Engineering News
Xconomy -FierceBiotech -Reuters
all 31 news articles »

 

Comments

Post a Comment
* Your Name:

* Your Email:

(NEVER publicly displayed)
Website URL:
* Security Image:
Security Image Generate New
Copy the numbers and letters from the security image:
 
* Your Comment:
No HTML tags are permitted in comments.
By submitting, you agree with our Publishing Policy. Please note that we may publish your comment in other sections of this site.